• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用高分辨率熔解曲线法检测VKORC1和CYP2C9的单核苷酸多态性。

High resolution melting method to detect single nucleotide polymorphism of VKORC1 and CYP2C9.

作者信息

Chen Chunxia, Li Siyue, Lu Xiaojun, Tan Bin, Huang Chunyan, Qin Li

机构信息

Department of Laboratory Medicine, West China Hospital, Sichuan University Chengdu 610041, China.

出版信息

Int J Clin Exp Pathol. 2014 Apr 15;7(5):2558-64. eCollection 2014.

PMID:24966969
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4069951/
Abstract

Single nucleotide polymorphisms (SNPs) of VKORC (1173T/C, rs9934438) and CYP2C9 (1075A/C, rs1057910) are major contributory factors on the sensitivity of warfarin in Chinese. Analysis of the two genomic loci could help warfarin treatment individual from bleeding or thrombosis events. An assay with the advantages of simplicity, speed, high sensitivity and low cost for genotyping is calling for clinical laboratories. High resolution method (HRM) meets these callings, but no study with large sample tested its performance in genotyping of rs9934438 and rs1057910. In this study, we identified polymorphisms of rs9934438 and rs1057910 in 255 unrelated Chinese heart valve replacement patients of Han ethnic group from West China Hospital. The two genomic loci were genotyped by HRM using LightCycler® 480 High Resolution Melting Master on LightCycler® 480 Real-Time PCR instruments (Roche Diagnostics), and all amplified PCR products were sent for direct DNA sequencing. The genotyping of rs1057910 between HRM and sequencing showed perfect 100% concordance. While the concordance of rs9934438 between HRM and sequencing was 99.2%. Unexpected mutation interfered genotyping results of HRM when genotyping rs9934438. HRM is a valuable technique for genotype detection of rs9934438 and rs1057910 to assess individual sensitivity to warfarin, where DNA sequencing is added inevitably sometimes.

摘要

维生素K环氧化物还原酶复合体亚单位1(VKORC)(1173T/C,rs9934438)和细胞色素P450 2C9(CYP2C9)(1075A/C,rs1057910)的单核苷酸多态性是影响华法林在中国人群中敏感性的主要因素。对这两个基因位点进行分析有助于避免华法林治疗个体出现出血或血栓形成事件。临床实验室需要一种具有操作简单、速度快、灵敏度高和成本低等优点的基因分型检测方法。高分辨率熔解曲线分析(HRM)方法符合这些要求,但尚无大样本研究测试其对rs9934438和rs1057910基因分型的性能。在本研究中,我们对来自华西医院的255名汉族非亲缘关系心脏瓣膜置换患者的rs9934438和rs1057910基因多态性进行了鉴定。使用罗氏诊断公司的LightCycler® 480实时荧光定量PCR仪上的LightCycler® 480高分辨率熔解曲线分析试剂盒,通过HRM对这两个基因位点进行基因分型,所有扩增的PCR产物均进行直接DNA测序。HRM与测序结果显示,rs1057910的基因分型一致性达100%。而rs9934438的HRM与测序结果的一致性为99.2%。在对rs9934438进行基因分型时,意外突变干扰了HRM的基因分型结果。HRM是一种用于检测rs9934438和rs1057910基因分型以评估个体对华法林敏感性的有价值技术,不过有时不可避免地需要进行DNA测序辅助。

相似文献

1
High resolution melting method to detect single nucleotide polymorphism of VKORC1 and CYP2C9.采用高分辨率熔解曲线法检测VKORC1和CYP2C9的单核苷酸多态性。
Int J Clin Exp Pathol. 2014 Apr 15;7(5):2558-64. eCollection 2014.
2
[Development of the high resolution melting method for genotyping CYP2C9*3 (1075A/C, rs1057910) and VKORC1 (-1639A/G, rs9923231)].[用于CYP2C9*3(1075A/C,rs1057910)和VKORC1(-1639A/G,rs9923231)基因分型的高分辨率熔解方法的开发]
Zhonghua Xin Xue Guan Bing Za Zhi. 2012 Jun;40(6):477-81.
3
[Influence of warfarin related genes and non- genetic factors on administrative dose in Shanghai area].[华法林相关基因及非遗传因素对上海地区给药剂量的影响]
Zhonghua Xue Ye Xue Za Zhi. 2014 Jan;35(1):13-7. doi: 10.3760/cma.j.issn.0253-2727.2014.01.004.
4
Genotyping of CYP2C9 and VKORC1 polymorphisms predicts south Indian patients with deep vein thrombosis as fast metabolizers of warfarin/acenocoumarin.CYP2C9和VKORC1基因多态性的基因分型预测南印度深静脉血栓患者对华法林/醋硝香豆素为快速代谢型。
Drug Discov Ther. 2017;11(4):198-205. doi: 10.5582/ddt.2017.01031.
5
[Impact of CYP2C9 and VKORC1 polymorphism on warfarin response during initiation of therapy].[CYP2C9和VKORC1基因多态性对华法林治疗起始阶段反应的影响]
Zhonghua Xin Xue Guan Bing Za Zhi. 2011 Oct;39(10):929-35.
6
Cross-Validation of High-Resolution Melting Analysis-Based Genotyping Platform.基于高分辨率熔解分析的基因分型平台的交叉验证
Genet Test Mol Biomarkers. 2017 Apr;21(4):259-264. doi: 10.1089/gtmb.2016.0317. Epub 2017 Feb 21.
7
Influence of UDP-Glucuronosyltransferase Polymorphisms on Stable Warfarin Doses in Patients with Mechanical Cardiac Valves.机械心脏瓣膜患者尿苷二磷酸葡萄糖醛酸转移酶多态性对稳定华法林剂量的影响。
Cardiovasc Ther. 2015 Dec;33(6):324-8. doi: 10.1111/1755-5922.12147.
8
Warfarin dose requirements with different genotypes of CYP2C9 and VKORC1 for patients with atrial fibrillation and valve replacement.心房颤动合并瓣膜置换患者不同CYP2C9和VKORC1基因型对华法林剂量的需求。
Int J Clin Pharmacol Ther. 2017 Feb;55(2):126-132. doi: 10.5414/CP202494.
9
CYP4F2 rs2108622: a minor significant genetic factor of warfarin dose in Han Chinese patients with mechanical heart valve replacement.CYP4F2 rs2108622:汉族机械心脏瓣膜置换患者华法林剂量的次要显著遗传因素。
Br J Clin Pharmacol. 2010 Aug;70(2):234-40. doi: 10.1111/j.1365-2125.2010.03698.x.
10
[Distribution of variant alleles association with warfarin pharmacokinetics and pharmacodynamics in the Han population in China].[中国汉族人群中与华法林药代动力学和药效学相关的变异等位基因分布]
Beijing Da Xue Xue Bao Yi Xue Ban. 2011 Dec 18;43(6):798-803.

引用本文的文献

1
Application of rapid genotyping of Warfarin individualized pharmacogenetic variants in Warfarin therapy.华法林个体化药物遗传学变异快速基因分型在华法林治疗中的应用。
Sci Rep. 2024 Dec 30;14(1):31639. doi: 10.1038/s41598-024-80639-0.
2
Rapid screening of gene variations by high resolution melting curve analysis.通过高分辨率熔解曲线分析快速筛查基因变异
Exp Ther Med. 2021 Apr;21(4):403. doi: 10.3892/etm.2021.9834. Epub 2021 Feb 25.
3
Technologies for Pharmacogenomics: A Review.《药物基因组学技术:综述》
Genes (Basel). 2020 Dec 4;11(12):1456. doi: 10.3390/genes11121456.
4
polymorphism is associated with an increased risk of familial cancer: evidence from a meta-analysis.基因多态性与家族性癌症风险增加相关:一项荟萃分析的证据。
Hered Cancer Clin Pract. 2017 Jun 13;15:8. doi: 10.1186/s13053-017-0068-7. eCollection 2017.
5
Development of a High-Resolution Melting Analysis Method for CYP2C19*17 Genotyping in Healthy Volunteers.健康志愿者中CYP2C19*17基因分型的高分辨率熔解分析方法的建立。
Avicenna J Med Biotechnol. 2016 Oct-Dec;8(4):193-199.
6
Prothrombin C20209T mutation in deep vein thrombosis: a case report.凝血酶原C20209T突变与深静脉血栓形成:一例报告
Int J Clin Exp Med. 2015 Jul 15;8(7):11225-9. eCollection 2015.

本文引用的文献

1
Development and comparison of a new personalized warfarin stable dose prediction algorithm in Chinese patients undergoing heart valve replacement.一种用于接受心脏瓣膜置换术的中国患者的新型华法林稳定剂量预测算法的开发与比较
Pharmazie. 2012 Nov;67(11):930-7.
2
Development of a high resolution melting method for genotyping of risk HLA-DQA1 and PLA2R1 alleles and ethnic distribution of these risk alleles.开发一种高分辨率熔解方法,用于 HLA-DQA1 和 PLA2R1 等位基因的基因分型,以及这些风险等位基因的种族分布。
Gene. 2013 Feb 10;514(2):125-30. doi: 10.1016/j.gene.2012.11.004. Epub 2012 Nov 27.
3
Rates of hemorrhage during warfarin therapy for atrial fibrillation.华法林治疗心房颤动期间的出血率。
CMAJ. 2013 Feb 5;185(2):E121-7. doi: 10.1503/cmaj.121218. Epub 2012 Nov 26.
4
The influence of VKORC1 and CYP2C9 gene sequence variants on the stability of maintenance phase warfarin treatment.VKORC1 和 CYP2C9 基因序列变异对维持期华法林治疗稳定性的影响。
Thromb Res. 2013 Feb;131(2):125-9. doi: 10.1016/j.thromres.2012.11.004. Epub 2012 Nov 16.
5
Influence of warfarin dose-associated genotypes on the risk of hemorrhagic complications in Chinese patients on warfarin.华法林剂量相关基因型对中国华法林患者出血并发症风险的影响。
Int J Hematol. 2012 Dec;96(6):719-28. doi: 10.1007/s12185-012-1205-8. Epub 2012 Oct 27.
6
Effect of genetic variants, especially CYP2C9 and VKORC1, on the pharmacology of warfarin.基因变异,尤其是 CYP2C9 和 VKORC1,对华法林药理学的影响。
Semin Thromb Hemost. 2012 Nov;38(8):893-904. doi: 10.1055/s-0032-1328891. Epub 2012 Oct 6.
7
[Development of the high resolution melting method for genotyping CYP2C9*3 (1075A/C, rs1057910) and VKORC1 (-1639A/G, rs9923231)].[用于CYP2C9*3(1075A/C,rs1057910)和VKORC1(-1639A/G,rs9923231)基因分型的高分辨率熔解方法的开发]
Zhonghua Xin Xue Guan Bing Za Zhi. 2012 Jun;40(6):477-81.
8
Clinical application of pharmacogenetic-based warfarin-dosing algorithm in patients of Han nationality after rheumatic valve replacement: a randomized and controlled trial.基于遗传药理学的华法林剂量算法在汉族风湿性心脏瓣膜置换术后患者中的临床应用:一项随机对照试验。
Int J Med Sci. 2012;9(6):472-9. doi: 10.7150/ijms.4637. Epub 2012 Aug 10.
9
[Distribution of variant alleles association with warfarin pharmacokinetics and pharmacodynamics in the Han population in China].[中国汉族人群中与华法林药代动力学和药效学相关的变异等位基因分布]
Beijing Da Xue Xue Bao Yi Xue Ban. 2011 Dec 18;43(6):798-803.
10
Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA.瑞典的抗凝控制:来自国家质量登记处 AuriculA 的治疗范围内时间、大出血和血栓栓塞并发症的报告。
Eur Heart J. 2011 Sep;32(18):2282-9. doi: 10.1093/eurheartj/ehr134. Epub 2011 May 26.